BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.8% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1726
SELLAS Life Sciences
SLS
$1.7B
| $222M | ﹤0.01% |
15,070,302
+2,871,892
| +24% | +$19.8M |
2016 Q4
38 quarters
|
|
1727
Gibraltar Industries
ROCK
$964M
| $222M | ﹤0.01% |
4,919,877
-129,110
| -3% | -$5.06M |
2013 Q2
52 quarters
|
|
1728
TAL Education Group
TAL
$5.64B
| $221M | ﹤0.01% |
23,137,168
-3,699,989
| -14% | -$38.9M |
2013 Q2
52 quarters
|
|
1729
SiteOne Landscape Supply
SITE
$4.86B
| $221M | ﹤0.01% |
1,934,754
-131,092
| -6% | -$15.8M |
2016 Q2
40 quarters
|
|
1730
Enliven Therapeutics
ELVN
$3.62B
| $221M | ﹤0.01% |
4,359,704
+674,997
| +18% | +$28.7M |
2020 Q2
24 quarters
|
|
1731
Amdocs
DOX
$4.39B
| $221M | ﹤0.01% |
4,375,383
+1,016,441
| +30% | +$62.3M |
2013 Q2
52 quarters
|
|
1732
Nutrien
NTR
$34.1B
| $221M | ﹤0.01% |
3,509,808
+428,773
| +14% | +$30M |
2018 Q1
33 quarters
|
|
1733
Pitney Bowes
PBI
$2.11B
| $220M | ﹤0.01% |
12,584,067
-2,089,794
| -14% | -$32M |
2013 Q2
52 quarters
|
|
1734
SoundHound AI
SOUN
$1.85B
| $220M | ﹤0.01% |
33,984,088
+1,575,327
| +5% | +$12.2M |
2022 Q2
16 quarters
|
|
1735
Xencor
XNCR
$2.66B
| $220M | ﹤0.01% |
13,651,261
+615,343
| +5% | +$7.69M |
2015 Q1
45 quarters
|
|
1736
CALL
iShares China Large-Cap ETF
FXI
$4.01B
| $220M | ﹤0.01% |
+6,952,600
| New | +$248M |
2026 Q2
0 quarters
|
|
1737
Lindsay Corp
LNN
$1.08B
| $219M | ﹤0.01% |
1,771,897
+32,834
| +2% | +$3.67M |
2013 Q2
52 quarters
|
|
1738
Liberty Live Group Series C
LLYVK
$9.8B
| $219M | ﹤0.01% |
2,074,659
+149,155
| +8% | +$14.5M |
2023 Q3
11 quarters
|
|
1739
Atlas Energy Solutions
AESI
$678M
| $219M | ﹤0.01% |
13,173,130
+1,682,276
| +15% | +$27.5M |
2023 Q1
13 quarters
|
|
1740
Enact Holdings
ACT
$6.38B
| $219M | ﹤0.01% |
4,780,711
+115,822
| +2% | +$4.95M |
2021 Q3
19 quarters
|
|
1741
iShares MBS ETF
MBB
$35.8B
| $218M | ﹤0.01% |
2,311,312
+88,923
| +4% | +$8.41M |
2015 Q4
42 quarters
|
|
1742
Wendy's
WEN
$1.55B
| $218M | ﹤0.01% |
26,314,724
+4,576,075
| +21% | +$32.7M |
2013 Q2
52 quarters
|
|
1743
First Advantage
FA
$4.04B
| $218M | ﹤0.01% |
12,063,590
+6,073,445
| +101% | +$88M |
2021 Q2
20 quarters
|
|
1744
Shinhan Financial Group
SHG
$29.4B
| $217M | ﹤0.01% |
3,433,734
+983,371
| +40% | +$64.5M |
2015 Q4
42 quarters
|
|
1745
CALL
SPDR Gold Trust
GLD
$136B
| $217M | ﹤0.01% |
589,500
-7,432,200
| -93% | -$3.08B |
2024 Q2
8 quarters
|
|
1746
Array Technologies
ARRY
$904M
| $217M | ﹤0.01% |
29,253,142
+66,056
| +0.2% | +$526K |
2020 Q4
22 quarters
|
|
1747
QuantumScape Corp
QS
$2.65B
| $216M | ﹤0.01% |
28,560,041
+6,750,353
| +31% | +$50.6M |
2021 Q1
21 quarters
|
|
1748
DELISTED
Select Medical
SEM
| $216M | ﹤0.01% |
13,073,640
-4,189,687
| -24% | -$69M |
2013 Q2
52 quarters
|
|
1749
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$3.45B
| $216M | ﹤0.01% |
1,865,930
-208,024
| -10% | -$19.7M |
2024 Q3
7 quarters
|
|
1750
AMN Healthcare
AMN
$1.4B
| $215M | ﹤0.01% |
6,643,401
+619,906
| +10% | +$16M |
2013 Q2
52 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 245 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 245 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.